These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 3775215

  • 1. The heart rate slowing effect of pindolol in patients with digitalis resistant atrial fibrillation and heart failure.
    Cristodorescu R, Roşu D, Deutsch G, Verdeş A, Luca C.
    Med Interne; 1986; 24(3):207-15. PubMed ID: 3775215
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B, Opolski G.
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [Abstract] [Full Text] [Related]

  • 4. [Comparison between digoxin and atenolol in chronic atrial fibrillation].
    Lanas F, Salvatici R, Castillo G, Montecinos A, Stockins B, Molina E.
    Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316
    [Abstract] [Full Text] [Related]

  • 5. [Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
    Oeff M, Beck OA, Hochrein H.
    Dtsch Med Wochenschr; 1979 Jan 19; 104(3):98-103. PubMed ID: 759158
    [Abstract] [Full Text] [Related]

  • 6. Heart rate control in patients with atrial fibrillation referred for exercise testing.
    Hilliard AA, Miller TD, Hodge DO, Gibbons RJ.
    Am J Cardiol; 2008 Sep 15; 102(6):704-8. PubMed ID: 18773992
    [Abstract] [Full Text] [Related]

  • 7. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS, Ghali WA, Sanfilippo AJ, Moritz S, Abdollah H.
    Am Heart J; 2001 Aug 15; 142(2):E3. PubMed ID: 11479482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
    Fukuda K, Handa S, Ogawa S, Nakamura Y, Kawamura Y.
    J Cardiol; 1990 Aug 15; 20(3):755-65. PubMed ID: 2151866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Aug 15; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical utility of plasma digoxin measurements.
    Cristodorescu R, Deutsch G, Drăgan S.
    Med Interne; 1989 Aug 15; 27(1):25-32. PubMed ID: 2749155
    [Abstract] [Full Text] [Related]

  • 17. [The use of digitalis glycosides in atrial fibrillation].
    Knez A, Haberl R, Steinbeck G.
    Z Kardiol; 1994 Aug 15; 83 Suppl 5():71-3. PubMed ID: 7846948
    [Abstract] [Full Text] [Related]

  • 18. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B.
    Am J Cardiol; 2009 Jan 15; 103(2):248-54. PubMed ID: 19121446
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms].
    Mérier GR, Perrenoud JJ.
    Schweiz Med Wochenschr; 1988 Jul 02; 118(26):1016-20. PubMed ID: 3413461
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.